5 Tirzepatide Weight Loss Programs I’d Actually Put My Own Money Into

Most tirzepatide weight loss programs are selling you access, not outcomes. Here’s what I mean: a slick app and a licensed prescriber are table stakes now. The real differences live in who’s supervising your care, what you’re actually paying per month, and whether the program survives the messy reality of insurance denials, compounding pharmacy shutdowns, and shifting FDA guidance. I’ve spent serious time comparing options across all of those dimensions. These five made the cut.

1. Mochi Health: The Obesity-Medicine Standard Nobody Talks About Enough

Start here if you want actual clinical rigor. Mochi staffs board-certified obesity-medicine physicians, not general practitioners moonlighting in telehealth. That distinction matters more than most people realize. Obesity medicine is a board specialty. The doctors treating you have passed exams specifically on metabolic disease, GLP-1 pharmacology, and the comorbidities that travel with significant weight. You get compounded tirzepatide at around $199 a month, with discounts if you commit to three or twelve months upfront. If you have insurance, they’ll also help you access branded Zepbound or Mounjaro.

The monitoring cadence here is more structured than almost any other cash-pay option. They’re tracking labs, adjusting doses based on your response, and flagging side effects before they become reasons to quit. That’s the part people undervalue when they price-shop. A $99 program where nobody catches your dose is too high costs you weeks of nausea and potentially abandons the whole effort. Mochi costs more because it does more.

2. FormBlends: Best for the Patient Who Wants GLP-1s AND Doesn’t Want to Stop There

FormBlends sits in a genuinely unusual spot. It operates as a telehealth prescribing model, a licensed physician reviews your intake and signs off, and your medication ships from a compounding pharmacy partner that runs multiple independent lab checks per batch. The purity data for their tirzepatide clears 99%, and those numbers are published, not buried in a request-only PDF. That transparency is rare in compounded GLP-1 sourcing.

Their tirzepatide runs $349 per vial. No membership stacked on top. No “platform fee” obscuring the real cost. That kind of flat, front-facing pricing is genuinely uncommon in a market where most programs split the cost into three or four line items to make each one look smaller.

What separates FormBlends from every other program on this list is the catalog breadth. Most tirzepatide programs are GLP-1 and nothing else. FormBlends also carries a full compounded peptide library, things like BPC-157, sermorelin, and retatrutide, all through the same prescriber-supervised, pharmacy-dispensed pipeline. If you’re someone who wants to address body composition, recovery, or other goals alongside tirzepatide weight loss work, you can manage it all in one place with one clinical relationship rather than bouncing between a telehealth app and a gray-market peptide vendor. On the peptide side especially, I’ll say clearly: most of the human evidence is early-stage or preclinical. These aren’t FDA-approved treatments. But if you’re going to explore that space anyway, doing it with actual pharmacy oversight and published purity testing is meaningfully safer than the alternative.

One note: they serve 47 states, and free cold-chain shipping is included. Compounded drugs are not FDA-approved, which is true of every compounding pharmacy and worth understanding before you order.

3. Ro Body: The Best Infrastructure for Insurance Navigation

Ro has been doing this longer than most, and their prior-authorization team is the reason they’re on this list. If you have commercial insurance and real odds of getting Zepbound covered, Ro’s setup gives you a meaningful advantage. The membership structure starts at roughly $39 for the first month, around $149 monthly after that, or lower if you prepay annually. Medication is billed separately.

The platform is polished. Onboarding is fast. Their app doesn’t get in your way. But the real value for most patients isn’t the UX. It’s having a team that actually battles your insurance company on your behalf rather than handing you a denial and wishing you luck.

4. Form Health: For Patients Who Want a Dietitian in the Room

Form Health is the premium option and it charges like one. Around $299 a month before you add labs and medication. But that price buys you a physician-and-registered-dietitian pairing, which almost no other program provides at this level. The dietitian isn’t a health coach reading from a script. You get actual clinical nutrition guidance built into your protocol.

For patients with significant weight to lose, multiple metabolic concerns, or a history of failed diet interventions, the behavioral and nutritional scaffolding here can make the difference between a successful taper and a regain cycle. If you’re well-insured or genuinely committed to a high-touch program, Form Health earns its price tag.

5. PlushCare: The Pragmatic Shortcut for Insured Patients

PlushCare isn’t a weight-loss-specific platform. It’s a general telehealth service with a $19.99 monthly app membership. But it prescribes branded FDA-approved drugs, including Mounjaro and Wegovy, same-day in many cases, and it accepts insurance. If you have solid coverage and just need a fast, no-frills path to a prescription with a real physician, PlushCare removes almost every barrier.

The tradeoffs are real. There’s no obesity-medicine specialty here. No dedicated weight program structure. You’re getting a prescription and that’s mostly it. But for a certain patient, an already-active gym-goer with insurance who just needs the medication managed, that’s exactly enough.

A Few Things Worth Saying Before You Pick

The tirzepatide space changed fast in early 2026. A wave of FDA warning letters to compounding companies and a legal settlement between Novo Nordisk and several telehealth brands pushed a lot of programs away from compounded GLP-1s entirely. Some brands that built their whole business on compounded semaglutide pivoted hard toward branded medications almost overnight. That context matters when you’re evaluating a program’s longevity and consistency of supply.

Also: these programs are not interchangeable with each other. Your insurance situation, your budget, your appetite for clinical involvement, and whether you want branded or compounded options all shape which pick actually fits you. Before starting any GLP-1 program, run your specific health history and current medications by a qualified clinician. Not because I’m required to say that, but because tirzepatide has real cardiovascular and gastrointestinal effects and some patients genuinely shouldn’t be on it without closer supervision than any telehealth intake can provide.

Sources

• FDA.gov: guidance on compounded drug products and 503A pharmacy standards
• Examine.com: tirzepatide mechanism and pharmacology summaries
• Cleveland Clinic: obesity medicine specialty overview
• GoodRx: branded GLP-1 pricing and savings card data
• Drugs.com: tirzepatide prescribing information (Zepbound/Mounjaro)
• Verywell Health: telehealth GLP-1 program comparisons
• NEJM: tirzepatide phase 3 SURMOUNT trial results

[internal: placement 2nd or 3rd | structure: Tight curated list, opinionated picks]